Expertise in
1
conditions

Rongyu Y. Zang-Yu Zang

180 Fenglin Road, 
Xuhui, CN 
Expertise in
1
conditions
180 Fenglin Road, 
Xuhui, CN 

Overview

Rongyu Zang-Yu Zang practices practicing medicine in Xuhui, China.

Zang-Yu Zang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Hysterectomy, and Oophorectomy.

They are actively involved in clinical research, co-authoring 66 peer reviewed articles and participating in 2 clinical trials.

Locations

180 Fenglin Road, Xuhui, 200032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery for Patients With Stage IIIC and IV Ovarian Cancer
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery for Patients With Stage IIIC and IV Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2025
Intervention Type: Procedure
Study Phase: Phase 3
Evaluation of Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase III, Multicenter, Randomized Trial
Evaluation of Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase III, Multicenter, Randomized Trial
Enrollment Status: Unknown
Publish Date: June 10, 2021
Intervention Type: Drug, Procedure
Study Drug: Salvage Chemotherapy
Study Phase: Phase 3
View 1 Less Clinical Trial

66 Total Publications

Retraction: Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis.
Retraction: Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis.
Journal: Oncotarget
Published: April 24, 2026

Frequently Asked Questions about Rongyu Y. Zang-Yu Zang

Is Rongyu Y. Zang-Yu Zang a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Rongyu Y. Zang-Yu Zang is classified as an Distinguished expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rongyu Y. Zang-Yu Zang participate in research or clinical trials?

Yes. Rongyu Y. Zang-Yu Zang has published 66 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Rongyu Y. Zang-Yu Zang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zang-Yu Zang's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile